“An indispensable addition to the field of drug studies. . . . Our jury admired Dufton's lucid, swift-moving prose, her great sense of historical context, and her ambition.”
— Jury, 2022 Silvers Grant for Work in Progress
“Dufton’s book traces the complex histories of the medications that are considered the gold standard in treating opioid addiction and addresses the pressing questions of why these half-century-old medications are still the primary way we’re confronting an epidemic that killed over 81,000 people last year.”
— Jury, 2021 J. Anthony Lukas Prizes for Work in Progress
“The US is awash in medications to treat opioid addiction but suffers unimaginable levels of opioid overdose deaths. It doesn’t have to be this way, Dufton argues. In Addiction, Inc., one of our most fluent historians of drug policy tells the gripping story of how addiction treatment went so wrong and introduces us to the often outsized personalities who struggled to keep it on track.”
— David Herzberg, author of “White Market Drugs: Big Pharma and the Hidden History of Addiction in America”
“Addiction, Inc. offers the first comprehensive history of medication-assisted addiction treatment and the people who pioneered it. Drawing on fresh research on methadone, naltrexone, buprenorphine, and other drug-based approaches to opioid addiction, Dufton shows how these treatments failed to live up to their early promise, thanks to a dog’s breakfast of politics, culture warring, and profiteering. It’s a remarkable story, told with confidence and flare.”
— David T. Courtwright, author of “The Age of Addiction: How Bad Habits Became Big Business”
“Dufton’s deep investigation of methadone—its medical, social, and political history—reveals its significant promise for treating opioid addiction. Transforming our partial realization of that promise into a flourishing therapeutic system is the plea at the heart of this meticulously researched book.”
— Sally L. Satel, coauthor of “Brainwashed: The Seductive Appeal of Mindless Neuroscience”
“Dufton has written the definitive history of medications for opioid use disorder—a deeply researched case study of how American healthcare dysfunction undermines effective treatment. Tracing how treatment became entangled with profit, stigma, and opportunism, Dufton effectively exposes the larger structural contradictions—economic, political, and moral—at the heart of our crisis. At a time when treatment and harm reduction face growing threats, this is essential reading for understanding how we got here and what genuine reform demands.”
— Carl Erik Fisher, author of “The Urge: Our History of Addiction”
“The definitive book on MAT, and a delightful, fast-paced read, Addiction, Inc. shows us how medicines intended to get us out of this mess may have helped get us into this mess in the first place.”
— Ben Westhoff, author of “Fentanyl, Inc.: How Rogue Chemists Are Creating the Deadliest Wave of the Opioid Epidemic”